EUVIMEDEUVIMED entdecken
CrossrefInfokarte

KDM4B Knockdown Attenuates Neurological Deficits in Ischemic Stroke by Inhibiting Neuronal Apoptosis Associated With Birc5 Upregulation

Siyu Deng, Nueraili Maihemuti, Mengjie Jia, Keli Huang, Mao Xie, Qi He, Jing Zhao

CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)

DOI: 10.1002/cns.71264 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background KDM4B (Lysine demethylase 4B), a histone lysine demethylase, exerts a crucial epigenetic regulatory role in the progression of numerous disorders by catalyzing demethylation reactions on target proteins. However, the precise biological function and molecular mechanism by which KDM4B regulates neurological deficits in ischemic stroke remains elusive. Methods In this study, we employed a mouse middle cerebral artery occlusion/reperfusion (MCAO/R) model and an oxygen–glucose deprivation/reoxygenation (OGD/R) model in HT22 neurons to mimic ischemic stroke. Targeted loss‐of‐function approaches were executed utilizing in vivo siRNA delivery and in vitro lentiviral shRNA transduction. The neuroprotective effects were systematically evaluated through infarct volume quantification, histopathological staining, and diverse sensorimotor behavioral tests. Furthermore, transcriptomic profiling (RNA‐seq) coupled with molecular biology assays was performed to elucidate the downstream apoptotic cascades and key targets governed by KDM4B. Results Herein, we found that KDM4B is predominantly localized in neurons, with its expression significantly decreasing initially and then gradually increasing following ischemic stroke. Loss‐of‐function experiments demonstrated that KDM4B knockdown mitigated brain damage, attenuated tissue structure disruption, and improved sensorimotor dysfunctions in mice with ischemic stroke. Additionally, KDM4B knockdown protected neurons against OGD/R insult. Furthermore, KDM4B knockdown inhibited the expression of Bax and the activation of the pro‐apoptotic caspase cascade (caspase‐3/6/7/8/9), while upregulating the expression of the anti‐apoptotic protein Bcl‐2, thereby reducing neuronal apoptosis. Mechanistically, KDM4B knockdown is associated with an upregulation of Birc5 expression, which in turn inhibits apoptotic progression in neurons. Conclusions These results demonstrate that KDM4B knockdown alleviates neurological deficits following ischemic stroke by inhibiting neuronal apoptosis, partially accompanied by Birc5.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →